Clayton, Dubilier & Rice ("CD&R" or the "Firm") today announced that Bill Galvin has been engaged as an Operating Advisor to ...
New Investment to Advance Vialto's Strategic Growth Initiatives and Enable Further Innovation in Technology and Teams Delivering Mobility, Tax, and Immigration Solutions to Clients Transaction ...
Resideo Technologies (REZI) has disclosed a new risk, in the Share Price & Shareholder Rights category. The CD&R Stockholder, holding approximately 11% of Resideo Technologies’ total voting power as ...
CVC and Clayton, Dubilier & Rice ("CD&R") today confirmed the completion of the previously announced investment in Epicor, a global provider of industry-specific enterprise software to promote ...
The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than cutting costs. Chris Hughes is a Bloomberg Opinion columnist covering ...
Kirkland & Ellis, Bredin Prat, Darrois Villey Maillot Brochier, Jones Day, Freshfields Bruckhaus Deringer, Latham & Watkins and DLA Piper are among the law firms advising on "exclusive ...
The New York City-based firm, CD&R, is attempting to acquire control of Sanofi subsidiary Opella. Sanofi said it was selling the company as part of its effort to focus on vaccines and innovative ...
Global investment firm CD&R on Monday announced an open offer to acquire a 26 per cent stake in Sanofi Consumer Healthcare India Ltd for an aggregate of up to Rs 2,983 crore. The development follows ...
Sanofi said on Monday (Oct 21) it had entered exclusive talks for the sale of a 50 per cent controlling stake in its consumer health business Opella to US private equity firm Clayton Dubilier & Rice ...
French pharmaceutical group Sanofi and US private equity firm Clayton Dubilier & Rice (CD&R) have entered exclusive negotiations regarding the partial takeover of Sanofi subsidiary Opella.
The deal would allow Sanofi to focus on its more lucrative, but riskier, innovative drugs and vaccines, and CD&R to take a 50% controlling stake in a business that is home to brands such as ...